Hazra Sarbani, Guha Rajdeep, Jongkey Geram, Palui Himangshu, Mishra Akhilesh, Vemuganti Geeta K, Basak Samar K, Mandal Tapan Kumar, Konar Aditya
West Bengal University of Animal & Fishery Sciences, Kolkata, India.
Mol Vis. 2012;18:1701-11. Epub 2012 Jun 22.
To evaluate the effect of ethylenediaminetetraacetic acid (EDTA) on posterior capsular opacification (PCO) of rabbits and to assess its effect on intraocular tissues.
Modulation of matrix metalloproteinase (MMP) activity in the aqueous following cataract surgery in rabbits and its prevention by different doses of EDTA was determined by zymography. For evaluation of PCO, lensectomized rabbits were intracamerally injected with single dose of either 5 mg EDTA or normal saline. After one month, the degree of PCO was determined by slitlamp biomicroscopy, Miyake-Apple view, and histology of the lens capsule. The effect of EDTA on intra ocular pressure (IOP), corneal endothelial cells, and the retina was evaluated by tonometry, specular microscopy and scanning electron microscopy, and electroretinography. The concentration of EDTA in the aqueous was determined by high performance liquid chromatography (HPLC) at different time points.
The MMP activity was significantly increased in the aqueous of the operated eyes, and EDTA reduced the degree of increase in a dose-dependent manner. EDTA treatment significantly reduced the degree of PCO (p<0.05). Histopathology of the lens capsule showed a reduction in the number of proliferating and migrating cells as well as MMP2 expression in the EDTA-treated eyes. EDTA treatment did not change the IOP; density, morphology and ultrastructure of the corneal endothelial cells; and electroretinography (ERG). EDTA was detectable in the aqueous humor up to 72 h following a single intracameral injection.
EDTA reduces the degree of PCO by suppressing the MMP activity and it is not toxic to intra ocular structures at the concentration used.
评估乙二胺四乙酸(EDTA)对兔后囊膜混浊(PCO)的影响,并评估其对眼内组织的作用。
通过酶谱法测定兔白内障手术后房水中基质金属蛋白酶(MMP)活性的调节情况以及不同剂量EDTA对其的预防作用。为评估PCO,对晶状体切除的兔眼进行前房内单次注射5mg EDTA或生理盐水。1个月后,通过裂隙灯显微镜检查、三浦-苹果视图和晶状体囊膜组织学检查确定PCO的程度。通过眼压测量、镜面显微镜检查、扫描电子显微镜检查和视网膜电图评估EDTA对眼压(IOP)、角膜内皮细胞和视网膜的影响。在不同时间点通过高效液相色谱(HPLC)测定房水中EDTA的浓度。
手术眼房水中MMP活性显著增加,EDTA以剂量依赖性方式降低其增加程度。EDTA治疗显著降低了PCO的程度(p<0.05)。晶状体囊膜的组织病理学显示,EDTA治疗组中增殖和迁移细胞的数量以及MMP2表达减少。EDTA治疗未改变眼压;角膜内皮细胞的密度、形态和超微结构;以及视网膜电图(ERG)。单次前房内注射后72小时内可在房水中检测到EDTA。
EDTA通过抑制MMP活性降低PCO程度,且在所使用的浓度下对眼内结构无毒。